dermatan sulfate has been researched along with Thrombotic Microangiopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaki, J; Ando, K; Aoyama, Y; Hara, R; Ichiki, A; Kawada, H; Kawai, H; Machida, S; Ogawa, Y; Onizuka, M; Toyosaki, M | 1 |
1 other study(ies) available for dermatan sulfate and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Topics: Adolescent; Adult; Chondroitin Sulfates; Dermatan Sulfate; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Thrombotic Microangiopathies | 2017 |